Optiscan and EMVision are among ASX healthcare companies reporting clinical milestones reached in quarterly results.

Abstract: Medical image processing is faced with the challenge of accurate diagnosis founded on image noise, blurriness, and lack of proper preprocessing. In this paper, our model introduced various ...

Juniper Biosciences today announced a strategic licensing agreement with Memorial Sloan Kettering Cancer Center (MSK) to ...

The 2026 CPT® updates bring sweeping changes to radiology coding, adding advanced imaging and interventional procedure codes while refining existing descriptors. With audits intensifying and ...

Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier ...

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...

APRIL IS HEAD AND NECK CANCER AWARENESS MONTH. THIS WEEKEND, LOCAL CANCER SURVIVORS, ADVOCATES AND BUSINESS SUPPORTERS ARE COMING TOGETHER TO RAISE MONEY FOR CRITICAL RESEARCH. JOINING ME NOW TO SHARE ...

Invasive pituitary adenomas with infrasellar extension can present with epistaxis and nasal obstruction, mimicking nasopharyngeal carcinoma (NPC) and leading to misdiagnosis. A 32‑year‑old male was ...

Alberta is expanding access to private health care in the province by introducing changes that would allow Albertans to access diagnostic screening and testing services without a referral. Primary and ...